These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
77 related articles for article (PubMed ID: 3537545)
21. Alemtuzumab induction therapy in highly sensitized kidney transplant recipients. Lü TM; Yang SL; Wu WZ; Tan JM Chin Med J (Engl); 2011 Mar; 124(5):664-8. PubMed ID: 21518554 [TBL] [Abstract][Full Text] [Related]
22. [Comparative study of defibrotide and calcium heparin in the prevention of postoperative deep venous thrombosis. A randomized multicenter study]. Battistel V; De Rosa A Minerva Med; 1988 Sep; 79(9):783-90. PubMed ID: 3050616 [TBL] [Abstract][Full Text] [Related]
23. Prevention of acute graft rejection by the prostaglandin E1 analogue misoprostol in renal-transplant recipients treated with cyclosporine and prednisone. Moran M; Mozes MF; Maddux MS; Veremis S; Bartkus C; Ketel B; Pollak R; Wallemark C; Jonasson O N Engl J Med; 1990 Apr; 322(17):1183-8. PubMed ID: 2109195 [TBL] [Abstract][Full Text] [Related]
24. Clinical outcomes during the first three months posttransplant in renal allograft recipients managed by C2 monitoring of cyclosporine microemulsion. Thervet E; Pfeffer P; Scolari MP; Toselli L; Pallardó LM; Chadban S; Pilmore H; Connolly J; Buchler M; Schena FP; Carreño CA; Dandavino R; Cole E Transplantation; 2003 Sep; 76(6):903-8. PubMed ID: 14508352 [TBL] [Abstract][Full Text] [Related]
25. [Results of kidney transplantation at the Institute of Urology and Nephrology of the Serbian Clinical Center in Belgrade]. Lezanić V; Djukanović Lj; Marinković J; Blagojević-Lazić R; Radivojević D; Simić-Ogrizović S; Milutinović D; Borić Z; Djokić M; Krasojević-Kostić I; Marković V; Petrović M; Dujić A; Hadzi-Djokić J Srp Arh Celok Lek; 2000; 128(5-6):149-56. PubMed ID: 11089414 [TBL] [Abstract][Full Text] [Related]
26. ABO-incompatible live donor renal transplantation using blood group A/B carbohydrate antigen immunoadsorption and anti-CD20 antibody treatment. Nordén G; Briggs D; Cockwell P; Lipkin G; Mjörnstedt L; Mölne J; Ready A; Rydberg L; Samuelsson O; Svalander CT; Breimer ME Xenotransplantation; 2006 Mar; 13(2):148-53. PubMed ID: 16623810 [TBL] [Abstract][Full Text] [Related]
27. Influence of aspirin on early allograft thrombosis and chronic allograft nephropathy following renal transplantation. Murphy GJ; Taha R; Windmill DC; Metcalfe M; Nicholson ML Br J Surg; 2001 Feb; 88(2):261-6. PubMed ID: 11167878 [TBL] [Abstract][Full Text] [Related]
28. [Use of defibrotide in the treatment of acute superficial thrombophlebitis of the legs]. Seccia M; Bortolotti P; Bellomini MG; Buccianti P; Chiarugi M; Cavina E Minerva Chir; 1989 May; 44(9):1379-84. PubMed ID: 2761740 [TBL] [Abstract][Full Text] [Related]
29. Long-term renal function in cyclosporine-treated renal allograft recipients. Tanabe K; Novick AC; Streem S; Hodge E Urology; 1995 Sep; 46(3):321-7. PubMed ID: 7660506 [TBL] [Abstract][Full Text] [Related]
30. Long-term efficacy and safety of cyclosporine in renal-transplant recipients. Burke JF; Pirsch JD; Ramos EL; Salomon DR; Stablein DM; Van Buren DH; West JC N Engl J Med; 1994 Aug; 331(6):358-63. PubMed ID: 8028616 [TBL] [Abstract][Full Text] [Related]
31. [Prevention of deep venous thrombosis. A prospective study of defibrotide]. Mensa G; Dominici P; Bouzari H; Colarelli G; Capusotti L; Dellepiane M Minerva Chir; 1988 Aug; 43(15-16):1275-8. PubMed ID: 3060758 [No Abstract] [Full Text] [Related]
32. [The effect of dipyridamole on the results of allogenic kidney transplantation]. Schulze R; Langkopf B; Sziegoleit W Z Urol Nephrol; 1990 May; 83(5):255-9. PubMed ID: 2203215 [TBL] [Abstract][Full Text] [Related]
33. A pilot evaluation of the effect of defibrotide in patients affected by peripheral arterial occlusive disease. Sabbá C; Zupo V; Dina F; Nazzari M; Albano O Int J Clin Pharmacol Ther Toxicol; 1988 May; 26(5):249-52. PubMed ID: 3045026 [TBL] [Abstract][Full Text] [Related]
34. Defibrotide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in vascular disorders. Palmer KJ; Goa KL Drugs; 1993 Feb; 45(2):259-94. PubMed ID: 7681375 [TBL] [Abstract][Full Text] [Related]
35. Effects of defibrotide in acute renal failure due to thrombotic microangiopathy. Vangelista A; Frascà GM; Raimondi C; Liviano-D'Arcangelo G; Bonomini V Haemostasis; 1986; 16 Suppl 1():51-4. PubMed ID: 3754836 [TBL] [Abstract][Full Text] [Related]
36. Effectiveness of defibrotide for prophylaxis of deep venous thrombosis after general surgery: a double-blind, placebo-controlled clinical trial. Mozzi E; Chiurazzi D; Germiniani R; Pacini F Haemostasis; 1986; 16 Suppl 1():36-8. PubMed ID: 3519382 [TBL] [Abstract][Full Text] [Related]
37. Effects of defibrotide in patients with chronic deep insufficiency. The PROVEDIS study. Coccheri S; Andreozzi GM; D'Addato M; Gensini GF; Int Angiol; 2004 Jun; 23(2):100-7. PubMed ID: 15507885 [TBL] [Abstract][Full Text] [Related]
38. Effectiveness of defibrotide for prophylaxis of deep venous thrombosis in gynecological surgery: a double-blind, placebo-controlled clinical trial. Ciavarella N; Ettorre C; Schiavoni M; Schonauer S; Cicinelli E; Cagnazzo G Haemostasis; 1986; 16 Suppl 1():39-41. PubMed ID: 3754834 [TBL] [Abstract][Full Text] [Related]
39. Clinical pharmacology and mode of action of a new antithrombotic compound: Defibrotide. Ulutin ON; Cizmeci G; Balkuv-Ulutin S Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):177-80. PubMed ID: 2459016 [TBL] [Abstract][Full Text] [Related]
40. Update on the use of defibrotide. Guglielmelli T; Bringhen S; Palumbo A Expert Opin Biol Ther; 2012 Mar; 12(3):353-61. PubMed ID: 22283742 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]